Option Care Health, Inc. (NASDAQ:OPCH) Receives $35.50 Average Price Target from Brokerages

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given an average recommendation of “Moderate Buy” by the eight research firms that are covering the stock, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year target price among analysts that have issued ratings on the stock in the last year is $35.50.

A number of research firms recently commented on OPCH. UBS Group raised shares of Option Care Health from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $38.00 to $40.00 in a report on Wednesday, April 30th. JPMorgan Chase & Co. lifted their price target on shares of Option Care Health from $40.00 to $41.00 and gave the stock an “overweight” rating in a report on Thursday, March 6th. JMP Securities reaffirmed a “market outperform” rating and set a $36.00 price objective on shares of Option Care Health in a report on Wednesday. Finally, Barrington Research reaffirmed an “outperform” rating and set a $38.00 price objective on shares of Option Care Health in a report on Wednesday, April 30th.

Institutional Investors Weigh In On Option Care Health

Institutional investors and hedge funds have recently modified their holdings of the company. JPMorgan Chase & Co. lifted its holdings in shares of Option Care Health by 29.6% in the fourth quarter. JPMorgan Chase & Co. now owns 1,511,403 shares of the company’s stock worth $35,065,000 after buying an additional 344,875 shares in the last quarter. MetLife Investment Management LLC lifted its holdings in shares of Option Care Health by 7.8% in the fourth quarter. MetLife Investment Management LLC now owns 197,219 shares of the company’s stock worth $4,575,000 after buying an additional 14,311 shares in the last quarter. Charles Schwab Investment Management Inc. lifted its holdings in shares of Option Care Health by 6.2% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company’s stock worth $58,235,000 after buying an additional 147,054 shares in the last quarter. Global Alpha Capital Management Ltd. lifted its holdings in shares of Option Care Health by 38.1% in the fourth quarter. Global Alpha Capital Management Ltd. now owns 68,810 shares of the company’s stock worth $1,596,000 after buying an additional 18,992 shares in the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new stake in shares of Option Care Health in the fourth quarter worth about $327,000. 98.05% of the stock is owned by hedge funds and other institutional investors.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $31.56 on Tuesday. The company has a market capitalization of $5.17 billion, a PE ratio of 25.45, a PEG ratio of 1.91 and a beta of 0.74. The company has a quick ratio of 1.02, a current ratio of 1.54 and a debt-to-equity ratio of 0.82. The stock’s 50 day moving average price is $32.08 and its 200-day moving average price is $30.48. Option Care Health has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a return on equity of 16.90% and a net margin of 4.12%. The business had revenue of $1.33 billion for the quarter, compared to analysts’ expectations of $1.26 billion. During the same quarter in the previous year, the firm earned $0.26 earnings per share. The business’s revenue was up 16.3% on a year-over-year basis. On average, equities analysts anticipate that Option Care Health will post 1.22 EPS for the current year.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.